[Present status of pharmacoradiology of the gastrointestinal tract (author's transl)].
Based upon the findings in over 1200 patients, technique, indication and validity of pharmacoradiology in examinations of esophagus, stomach, duodenum, small and large intestine are critically evaluated and summarized. Dosis, effects, side effects and contraindications of the mostly applied pharmaca (Buscopan, Pro-Banthine, Paspertin, Glucagon, Cholecystokinin and Caerulein) are listed. The value of pharmacoradiology of the gastrointestinal tract for clinical roentgenology is stressed.
D002086:Butylscopolammonium Bromide; D002108:Ceruletide / Q000494:pharmacology; D003108:Colonic Diseases / Q000000981:diagnostic imaging; D004378:Duodenal Diseases / Q000000981:diagnostic imaging; D004931:Esophageal Achalasia / Q000000981:diagnostic imaging; D004935:Esophageal Diseases / Q000000981:diagnostic imaging; D004932:Esophageal and Gastric Varices / Q000000981:diagnostic imaging; D005767:Gastrointestinal Diseases / Q000000981:diagnostic imaging*; D005769:Gastrointestinal Motility / Q000187:drug effects; D006551:Hernia, Hiatal / Q000000981:diagnostic imaging; D006801:Humans; D007583:Jejunum / Q000000981:diagnostic imaging; D008722:Methods; D011859:Radiography; D013272:Stomach Diseases / Q000000981:diagnostic imaging
D002086:Butylscopolammonium Bromide; D002108:Ceruletide
Gegenwärtiger Stand der Pharmakoradiologie des Magen-Darm-Traktes